Clinical Trials
4
Active:1
Completed:2
Trial Phases
2 Phases
Phase 2:2
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 4
1 (33.3%)Quaternium-15, Use Test
Phase 4
- Conditions
- Allergic Contact Dermatitis Towards Quaternium-15
- First Posted Date
- 2006-04-06
- Last Posted Date
- 2006-04-06
- Lead Sponsor
- Mekos Laboratories AS
- Target Recruit Count
- 10
- Registration Number
- NCT00311454
- Locations
- 🇩🇰
Amtssygehuset i Gentofte, Gentofte, Denmark
Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate
Phase 2
Completed
- Conditions
- Allergic Contact Dermatitis
- First Posted Date
- 2005-08-23
- Last Posted Date
- 2006-02-27
- Lead Sponsor
- Mekos Laboratories AS
- Target Recruit Count
- 60
- Registration Number
- NCT00133341
- Locations
- 🇩🇰
Odense University Hospital, Odense, Odense C, Denmark
Clinical Evaluation of Bacitracin
Phase 2
Completed
- Conditions
- Allergic Contact Dermatitis
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2005-10-19
- Lead Sponsor
- Mekos Laboratories AS
- Target Recruit Count
- 20
- Registration Number
- NCT00132600
- Locations
- 🇺🇸
Dermatological Clinic (Joseph Fowler MD), Louisville, Kentucky, United States
News
No news found